Recap: Inspire Medical Systems Q3 Earnings

Shares of Inspire Medical Systems (NYSE:INSP) rose 9.53% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were down 14.71% over the past year to ($0.39), which beat the estimate of ($0.72).

Revenue of $35,842,000 higher by 71.81% from the same period last year, which beat the estimate of $22,750,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

The upcoming fiscal year's revenue expected to be between $110,000,000 and $112,000,000.

Details Of The Call

Date: Nov 02, 2020

Time: 05:00 PM

ET Webcast URL: http://public.viavid.com/player/index.php?id=141564

Price Action

Company's 52-week high was at $135.20

Company's 52-week low was at $40.53

Price action over last quarter: Up 11.81%

Company Profile

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.